SR 9009, also referred to as Stenabolic, was created by The Scripps Study Institute by professor Thomas Burris, Ph.D, Professor and Director of your Center for Diabetes and Metabolic Ailments. Professor Burris does investigation in drug discovery improvement for type 1 and kind 2 diabetes, obesity and atherosclerosis (clogged arteries), and around the connection involving circadian rhythms and metabolic illnesses. He's one of several top rated developers of drugs that influence metabolism and power levels. He is also an specialist on metabolic illnesses and conditions, plus the impact of circadian rhythms upon them.

SR 9009 is actually a nuclear receptor reversed-viral erythroblastosis a (Rev-erba) ligand which can be taken orally. It's accessible in powder, liquid, and capsule types. Rev-erba regulates the expression of core clock proteins and therefore helps to modulate circadian rhythm. This can influence metabolism, power levels, stamina, and mobility.